1. Faienza MF, Farella I, Khalil M, Portincasa P. Converging pathways between metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes in children. Int J Mol Sci 2024; 25: 9924.
2.
Panganiban J, Kehar M, Ibrahim SH, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective. Obes Pillars 2025; 14: 100164.
3.
Shi GX, Qian YS, Jiang CM, et al. Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents: Authors’ name. Sci Rep 2024; 14: 25724.
4.
Stierman B, Afful J, Carroll M, et al. National health and nutrition examination survey 2017–march 2020. Natl Health Stat Rep 2020.
5.
Cuda S, Censani M, O’Hara V, et al. Special considerations for the child with obesity: An Obesity Medicine Association (OMA) clinical practice statement (CPS) 2024. Obes Pillars 2024; 11: 100113.
6.
Rinella ME, Lazarus JV, Ratziu V, et al. Wielokulturowe oświad-
7.
czenie konsensusu Delphi dotyczące nowej nomenklatury stłuszczeniowej choroby wątroby. Hepatologia 2023; 78: 1966-1986.
8.
Liu Y, Wang Y, Xing Y, et al. Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6-14 years in China and its applications in high-obesity-risk countries and regions RSS. Lancet Reg Health West Pac 2024; 49: 101150.
9.
Huneault HE, Lo JS, Bai S, et al. Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction-associated steatotic liver disease in youth. Hepatol Commun 2024; 8: e0582.
10.
de Boom F, Talib A, Roebroek YGM, et al. Non-invasive assessment of metabolic dysfunction-associated steatotic liver disease in adolescents with severe obesity; patient characteristics and association with leptin-a cross-sectional overview of baseline data from a RCT. Children 2024; 11: 965.
11.
Wang H, Wu S, Weng Y, et al. Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity. Ital J Pediatr 2024; 50: 162.
12.
Song K, Seol EG, Yang H, et al. Bioelectrical impedance parameters add incremental value to waist-to-hip ratio for prediction of metabolic dysfunction associated steatotic liver disease in youth with overweight and obesity. Front Endocrinol (Lausanne) 2024; 15: 1385002.
13.
Zdanowicz K, Kopiczko N, Flisiak-Jackiewicz M, et al. Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease. Clin Exp Hepatol 2024; 10: 188-193.
14.
Kopiczko N, Bobrus-Chociej A, Harasim-Symbor E, et al. Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children. Clin Exp Hepatol 2024; 10: 278-284.
15.
Jamil A, Chivese T, Elshaikh U, et al. Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD in children and adolescents: a systematic review and meta-analysis. BMC Public Health 2024; 24: 2701.
16.
Serbis A, Polyzos SA, Paschou SA, et al. Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children? Endocrine 2024; 85: 988-1006.
17.
Le Garf S, Negre V, Anty R, et al. Metabolic fatty liver disease in children: A growing public health problem. Biomedicines 2021; 9: 1915.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
